Clinical Trial Update: Real World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell Lymphoma

View source ↗

Summary

This clinical trial explores real-world use of an academic anti-CD19 CAR-T cell therapy for relapse/refractory diffuse large B-cell lymphoma and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Academic anti-CD19 CAR-T cell therapy

Snippet

Sponsor: N.N. Alexandrov National Cancer Centre | Conditions: Large B-Cell Lymphoma (LBCL) | Status: RECRUITING